Deafness Due to Degeneration of Cochlear Neurons in Caspase-3-Deficient Mice

Mice that lack caspase-3, which functions in apoptosis, were generated by gene targeting and shown to undergo hearing loss. The ABR threshold of the caspase-3−/− mice was significantly elevated compared to that of caspase-3+/+ mice at 15 days of age and was progressively elevated further by 30 days....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 2001-06, Vol.284 (1), p.142-149
Hauptverfasser: Morishita, Hirofumi, Makishima, Tomoko, Kaneko, Chie, Lee, Yun-Shain, Segil, Neil, Takahashi, Katsuhiko, Kuraoka, Akio, Nakagawa, Takashi, Nabekura, Junichi, Nakayama, Keiko, Nakayama, Kei-Ichi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Mice that lack caspase-3, which functions in apoptosis, were generated by gene targeting and shown to undergo hearing loss. The ABR threshold of the caspase-3−/− mice was significantly elevated compared to that of caspase-3+/+ mice at 15 days of age and was progressively elevated further by 30 days. Distortion product otoacoustic emissions were not detectable in caspase-3−/− mice at 15 days of age. Caspase-3−/− mice exhibited marked degeneration of spiral ganglion neurons and a loss of inner and outer hair cells in the cochlea at 30 days of age, although no such changes were apparent at 15 days. The degenerating neurons manifested features, including cytoplasmic vacuolization, distinct from those characteristic of apoptosis. Spiral ganglion neurons and cochlear hair cells thus appear to require caspase-3 for survival but not for initial development. The mapping of both the human caspase-3 gene and the locus responsible for an autosomal dominant, nonsyndromic form of hearing loss (DFNA24) to chromosome 4q35 suggests that the caspase-3−/− mice may represent a model of this human condition.
ISSN:0006-291X
1090-2104
DOI:10.1006/bbrc.2001.4939